Literature DB >> 12837840

KIT in ovarian carcinoma: disillusion about a potential therapeutic target.

Gad Singer, Peter Schraml, Christopher Belgard, Anna Raggi, Stephan Dirnhofer, Philip Went, Michael J Mihatsch, Holger Moch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12837840     DOI： 10.1093/jnci/95.13.1009-a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Expression of c-Kit and PDGFRα in epithelial ovarian tumors and tumor stroma.

Authors:  Cunjian Yi; Li Li; Keming Chen; Shengrong Lin; Xiangqiong Liu
Journal:  Oncol Lett       Date:  2011-11-15       Impact factor: 2.967

2.  Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy.

Authors:  Chouhei Sakakura; Akeo Hagiwara; Koji Soga; Koji Miyagawa; Susumu Nakashima; Tetsuji Yoshikawa; Shuichi Kin; Yuenn Nakase; Nobuki Yamaoka; Yoshihiko Sagara; Hisakazu Yamagishi
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

3.  Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.

Authors:  H Lassus; H Sihto; A Leminen; S Nordling; H Joensuu; N N Nupponen; R Butzow
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.